for the Period Ended 30 June 2023
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 30 June 2023
Directors
The director shown below has held office during the whole of the period from
16 June 2022 to 30 June 2023
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
2023 | ||
---|---|---|
| £ | |
Administrative expenses: | ( | |
Operating profit(or loss): | ( | |
Profit(or loss) before tax: | ( | |
Profit(or loss) for the financial year: | ( |
As at
Notes | 2023 | ||
---|---|---|---|
| £ | ||
Creditors: amounts falling due within one year: | 3 | ( | |
Net current assets (liabilities): | ( | ||
Total assets less current liabilities: | ( | ||
Total net assets (liabilities): | ( | ||
Members' funds | |||
Profit and loss account: | ( | ||
Total members' funds: | ( |
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 June 2023
Basis of measurement and preparation
for the Period Ended 30 June 2023
2023 | ||
---|---|---|
Average number of employees during the period | |
for the Period Ended 30 June 2023
2023 | ||
---|---|---|
£ | ||
Other creditors | | |
Total | |
The objective of the company is to provide ease of access to information, support and services relating to women's health, specifically miscarriage, fertility and certain medical conditions.In this first year of operation, connections have been made with other related businesses in the industry to build relationships in the hope to collaborate and work together in the future. Research has also been conducted to understand what topics are of most importance to potential clients and people going through their own fertility journey in order to provide the best support once live. Initial quotes have been obtained to develop company branding and website.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
6 March 2024
And signed on behalf of the board by:
Name: Kimberley Louise Olsson
Status: Director